Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated.
CHI’S Pharmacogenomics Now: Maximizing Benefits/Minimizing Risk
5 - 6 November 2008, Montreal, Quebec, Canada
Introduction
Venue
Hotel Omni Mont-Royal
Hotel Omni Mont-Royal, Montreal, Quebec, Canada
Useful links
Organised by
Cambridge Healthtech Institute
Contact information
Related events
Forensic serology and DNA analysis laboratory training
27 May 2024 09:00 - 31 May 2024 16:00, KISUMU, Kenya
Psychedelic Drugs and Forensic Analytical Techniques - CG Summer Meeting & AGM (Rearranged Event)
3 July 2024 11:00-15:30, London, United Kingdom
Future Labs Live
26 June 2024 08:00 - 27 June 2024 17:00, Basel, Switzerland
What did Humphry Davy write in his notebooks?
25 June 2024 19:00-20:00, Lancaster, United Kingdom
Search
Advertisement
Spotlight
Explore
